查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927002

全球医用同位素市场报告（2026 年）

Medical Isotopes Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，医用同位素市场规模显着成长，预计将从2025年的72.6亿美元成长到2026年的77.9亿美元，复合年增长率（CAGR）为7.4%。过去几年的成长可归因于Technetium-99m在诊断领域的广泛应用、医院核子医学科室的扩建、癌症诊断率的提高、对核子反应炉同位素供应的依赖以及医学影像设备的进步。

预计未来几年医用同位素市场将稳定成长，到2030年市场规模将达到100.5亿美元，复合年增长率（CAGR）为6.6%。预测期内的成长要素包括慢性病盛行率上升、标靶放射治疗需求成长、迴旋加速器设施投资增加、个人化医疗发展以及同位素生产技术进步。预测期内的主要趋势包括放射性同位素在诊断成像中的应用日益广泛、核医学疗法的普及、精准肿瘤治疗需求增长、基于迴旋加速器的同位素生产规模扩大以及对短寿命同位素供应链的日益重视。

癌症和心臟病发病率的上升预计将在未来推动医用同位素市场的成长。癌症和心臟病发病率反映了这些疾病在特定时期内于人群中发生和持续的频率，反映了更广泛的公共卫生趋势和预防策略的有效性。这些疾病发生率的上升趋势与现代久坐的生活方式密切相关，而现代久坐的生活方式又源于科技产品的使用和文书工作的工作，导致人们的身体活动水平下降。医用同位素在癌症和心臟病的诊断和治疗中发挥重要作用，其应用包括正子断层扫描（PET）和单光子发射电脑断层扫描（SPECT）等影像方法，以及放射疗法和放射性支架等治疗应用。例如，根据麦克米伦癌症援助组织的数据，截至2024年8月，英国有超过300万人患有癌症，预计到2025年这一数字将达到350万，到2030年将达到400万，到2040年将达到530万。因此，癌症和心臟病发病率的上升正在推动医用同位素市场的成长。

医用同位素市场的主要企业正致力于透过策略联盟来增强其竞争优势。策略联盟是指组织之间为追求通用目标并实现互利共赢而建立的正式伙伴关係。例如，2023年9月，总部位于美国的医疗技术公司International Isotopes Inc.与总部位于美国的生物医学设备製造商Phantech Medical达成合作，旨在为客户提供整合解决方案。透过此次合作，两家公司致力于设计、製造和销售创新的密封同位素源，以支持医学成像和治疗诊断（治疗诊断学）应用，从而改变临床前成像领域的校准和参考源市场。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球医用同位素市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧与自主智能
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料和网路安全
    • 永续性、气候技术和循环经济
  • 主要趋势
    • 诊断影像中放射性同位素的使用日益增多
    • 扩大核医学疗法的应用
    • 精准肿瘤治疗的需求日益增长
    • 利用迴旋加速器扩大同位素生产。
    • 日益关注短寿命同位素供应链

第五章 终端用户产业市场分析

  • 医院
  • 诊断影像中心
  • 核子医学诊所
  • 研究所
  • 癌症治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球医用同位素市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球医用同位素市场规模、对比及成长率分析
  • 全球医用同位素市场表现：规模与成长，2020-2025年
  • 全球医用同位素市场预测：规模与成长，2025-2030年，2035年

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 依产品类型
  • 诊断用放射性同位素、治疗放射性同位素、治疗及诊断用放射性同位素
  • 透过製造方法
  • 中子活化分析、迴旋加速器法、核子反应炉法及其他製造方法
  • 透过使用
  • 诊断影像、标靶放射性核种治疗、近距离放射治疗、放射性药物研发
  • 按最终用途
  • 医院、影像诊断中心、研究机构
  • 按类型对诊断用放射性同位素进行细分
  • Technetium-99m、氟-18、镓-68、碘-123、碳-11和其他诊断用放射性同位素
  • 治疗性放射性同位素按类型细分
  • 碘 131、镏-177、钇 90、锶 89、钐 153、锕 225 等治疗放射性同位素
  • 按类型对治疗和诊断放射性同位素进行细分
  • 镓-68/镏-177放射性同位素对、铜-64/铜-67放射性同位素对、碘-123/碘-131放射性同位素对、钪-44/钪-47放射性同位素对、铽同位素对以及其他治疗和诊断用放射性同位素

第十章 区域与国家分析

  • 全球医用同位素市场：依地区、绩效及预测划分，2020-2025年、2025-2030年、2035年
  • 全球医用同位素市场：依国家、绩效及预测划分，2020-2025年、2025-2030年、2035年

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 医用同位素市场：竞争格局及市场占有率（2024年）
  • 医用同位素市场：公司估值矩阵
  • 医用同位素市场：公司概况
    • Rosatom State Atomic Energy Corporation
    • Bayer AG
    • Siemens Healthineers AG
    • GE HealthCare
    • Urenco Ltd.

第37章：其他领先和创新企业

  • Lantheus Holdings Inc.、Curium Pharma、Canadian Nuclear Laboratories、Eckert & Ziegler Strahlen-und Medizintechnik AG.、Advanced Accelerator Applications（诺华公司旗下）、Nordion Inc.、NTP Radioisotopes SOC Ltd.、放射性元素研究所 (IREIRE)、NorthStar移植(ITM)、EczacIbasI-Monrol Nuclear Products Co.、SHINE Medical Technologies LLC、Blue Earth Diagnostics Limited、Isologic Innovative Radiopharmaceuticals、IBA Radiopharma Solutions

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：具有高市场潜力的国家及其策略

  • 2030年医用同位素市场：提供新机会的国家
  • 2030年医用同位素市场：充满新机会的细分市场
  • 2030年医用同位素市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: CH3MMISO01_G26Q1

Medical isotopes are radioisotopes utilized in medicine, emitting positrons or gamma rays for diagnostic purposes. These isotopes aid in visualizing and targeting specific tissues or abnormalities within the body, facilitating tasks such as evaluating heart function, assessing blood flow to the heart muscle, and diagnosing coronary artery disease.

The main product types of medical isotopes comprise stable isotopes and radioisotopes. Stable isotopes are versions of chemical elements that do not decay over time, retaining their atomic structure indefinitely. Production methods for medical isotopes include neutron activation, cyclotrons, nuclear reactors, and others. These isotopes find applications in nuclear therapy, equipment radioactive sources, and diagnostic procedures. End users of medical isotopes include hospitals, diagnostic centers, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the medical isotopes market by increasing costs related to imported nuclear materials, specialized equipment, and isotope processing components essential for medical applications. These impacts are most evident in diagnostic and therapeutic isotope supply chains across north america, europe, and asia pacific, where cross border movement of radioactive materials is tightly regulated. Higher costs and logistical delays have challenged timely isotope availability for hospitals and diagnostic centers. Conversely, tariffs have driven investments in domestic production facilities, cyclotron installations, and localized supply networks, improving long term supply security and healthcare resilience.

The medical isotopes market research report is one of a series of new reports from The Business Research Company that provides medical isotopes market statistics, including medical isotopes industry global market size, regional shares, competitors with a medical isotopes market share, detailed medical isotopes market segments, market trends and opportunities, and any further data you may need to thrive in the medical isotopes industry. This medical isotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical isotopes market size has grown strongly in recent years. It will grow from $7.26 billion in 2025 to $7.79 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to established use of technetium 99m in diagnostics, expansion of hospital nuclear medicine departments, growth in cancer diagnosis rates, reliance on nuclear reactors for isotope supply, advances in medical imaging equipment.

The medical isotopes market size is expected to see strong growth in the next few years. It will grow to $10.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, rising demand for targeted radiotherapy, investment in cyclotron infrastructure, growth of personalized medicine, technological advancements in isotope production methods. Major trends in the forecast period include rising use of radioisotopes in diagnostic imaging, growing adoption of nuclear medicine therapies, increasing demand for precision oncology treatments, expansion of cyclotron based isotope production, higher focus on short lived isotope supply chains.

The rising cancer and heart disease rates are expected to propel the growth of the medical isotope market going forward. Cancer and heart disease rates refer to how frequently these conditions occur and persist within a population over a given period, reflecting broader public health patterns and the effectiveness of prevention strategies. The increasing prevalence of these diseases is linked to modern sedentary lifestyles driven by technology use and desk-based occupations, which reduce physical activity levels. Medical isotopes play a critical role in diagnosing and treating cancer and heart disease through imaging modalities such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as in therapeutic applications including radiation therapy and radioactive stents. For instance, in August 2024, according to Macmillan Cancer Support, more than 3 million people in the UK were living with cancer, a number projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, rising cancer and heart disease rates are driving the growth of the medical isotope market.

Major companies in the medical isotope market are focusing on strategic collaborations to strengthen their competitive position. Strategic collaborations involve formal partnerships between organizations to pursue shared goals and deliver mutually beneficial outcomes. For example, in September 2023, International Isotopes Inc., a US-based medical technology company, partnered with Phantech Medical, a US-based biomedical hardware manufacturer, to integrate solutions for their customers. Through this collaboration, the companies aim to transform the calibration and reference sources market for pre-clinical imaging by designing, manufacturing, and distributing innovative sealed sources that support medical imaging and theranostics applications.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biopharmaceutical company, acquired ARTMS Inc. for an undisclosed amount. This acquisition provides Telix with enhanced access to ARTMS' cutting-edge radiopharmaceutical production technologies, strengthening its capabilities in developing and commercializing targeted radiopharmaceuticals for cancer imaging and therapy. ARTMS Inc. is a Canada-based medical equipment manufacturer specializing in technologies that improve the production of diagnostic imaging isotopes.

Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien Munchen AG (ITM), EczacIbasI-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotop, Coqui RadioPharmaceuticals Corp., Jubilant DraxImage Inc.

North America was the largest region in the medical isotopes market in 2025. The regions covered in the medical isotopes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the medical isotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The medical isotopes market consists of sales of technetium-99m, carbon-11, and gallium-68 which serve specific purposes in medical diagnosis and therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Isotopes Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical isotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical isotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical isotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Diagnostic Radioisotopes; Therapeutic Radioisotopes; Theranostic Radioisotopes
  • 2) By Production Method: Neutron Activation; Cyclotron; Nuclear Reactor; Other Production Method
  • 3) By Application: Diagnostic Imaging; Targeted Radionuclide Therapy; Brachytherapy; Radiopharmaceutical Research & Development
  • 4) By End Use: Hospitals; Diagnostic Imaging Centers; Research Institutes
  • Subsegments:
  • 1) By Diagnostic Radioisotopes: Technetium-99m; Fluorine-18; Gallium-68; Iodine-123; Carbon-11; Other Diagnostic Radioisotopes
  • 2) By Therapeutic Radioisotopes: Iodine-131; Lutetium-177; Yttrium-90; Strontium-89; Samarium-153; Actinium-225; Other Therapeutic Radioisotopes
  • 3) By Theranostic Radioisotopes: Gallium-68 / Lutetium-177 Pairs; Copper-64 / Copper-67 Pairs; Iodine-123 / Iodine-131 Pairs; Scandium-44 / Scandium-47 Pairs; Terbium Isotope Pairs; Other Theranostic Radioisotopes
  • Companies Mentioned: Rosatom State Atomic Energy Corporation; Bayer AG; Siemens Healthineers AG; GE HealthCare; Urenco Ltd.; Lantheus Holdings Inc.; Curium Pharma; Canadian Nuclear Laboratories; Eckert & Ziegler Strahlen- und Medizintechnik AG.; Advanced Accelerator Applications a Novartis company; Nordion Inc.; NTP Radioisotopes SOC Ltd.; The Institute for Radioelements (IRE); NorthStar Medical Radioisotopes LLC; Isotopen Technologien Munchen AG (ITM); EczacIbasI-Monrol Nuclear Products Co.; SHINE Medical Technologies LLC; Blue Earth Diagnostics Limited; Isologic Innovative Radiopharmaceuticals; IBA Radiopharma Solutions; Izotop; Coqui RadioPharmaceuticals Corp.; Jubilant DraxImage Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Medical Isotopes Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Medical Isotopes Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Medical Isotopes Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Medical Isotopes Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Rising Use Of Radioisotopes In Diagnostic Imaging
    • 4.2.2 Growing Adoption Of Nuclear Medicine Therapies
    • 4.2.3 Increasing Demand For Precision Oncology Treatments
    • 4.2.4 Expansion Of Cyclotron Based Isotope Production
    • 4.2.5 Higher Focus On Short Lived Isotope Supply Chains

5. Medical Isotopes Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Imaging Centers
  • 5.3 Nuclear Medicine Clinics
  • 5.4 Research Institutes
  • 5.5 Cancer Treatment Centers

6. Medical Isotopes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Medical Isotopes Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Medical Isotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Medical Isotopes Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Medical Isotopes Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Medical Isotopes Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Medical Isotopes Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Medical Isotopes Market Segmentation

  • 9.1. Global Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Radioisotopes, Therapeutic Radioisotopes, Theranostic Radioisotopes
  • 9.2. Global Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method
  • 9.3. Global Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Imaging, Targeted Radionuclide Therapy, Brachytherapy, Radiopharmaceutical Research & Development
  • 9.4. Global Medical Isotopes Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Imaging Centers, Research Institutes
  • 9.5. Global Medical Isotopes Market, Sub-Segmentation Of Diagnostic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Technetium-99m, Fluorine-18, Gallium-68, Iodine-123, Carbon-11, Other Diagnostic Radioisotopes
  • 9.6. Global Medical Isotopes Market, Sub-Segmentation Of Therapeutic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Iodine-131, Lutetium-177, Yttrium-90, Strontium-89, Samarium-153, Actinium-225, Other Therapeutic Radioisotopes
  • 9.7. Global Medical Isotopes Market, Sub-Segmentation Of Theranostic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gallium-68 / Lutetium-177 Pairs, Copper-64 / Copper-67 Pairs, Iodine-123 / Iodine-131 Pairs, Scandium-44 / Scandium-47 Pairs, Terbium Isotope Pairs, Other Theranostic Radioisotopes

10. Medical Isotopes Market Regional And Country Analysis

  • 10.1. Global Medical Isotopes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Medical Isotopes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Medical Isotopes Market

  • 11.1. Asia-Pacific Medical Isotopes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Medical Isotopes Market

  • 12.1. China Medical Isotopes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Medical Isotopes Market

  • 13.1. India Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Medical Isotopes Market

  • 14.1. Japan Medical Isotopes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Medical Isotopes Market

  • 15.1. Australia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Medical Isotopes Market

  • 16.1. Indonesia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Medical Isotopes Market

  • 17.1. South Korea Medical Isotopes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Medical Isotopes Market

  • 18.1. Taiwan Medical Isotopes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Medical Isotopes Market

  • 19.1. South East Asia Medical Isotopes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Medical Isotopes Market

  • 20.1. Western Europe Medical Isotopes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Medical Isotopes Market

  • 21.1. UK Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Medical Isotopes Market

  • 22.1. Germany Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Medical Isotopes Market

  • 23.1. France Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Medical Isotopes Market

  • 24.1. Italy Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Medical Isotopes Market

  • 25.1. Spain Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Medical Isotopes Market

  • 26.1. Eastern Europe Medical Isotopes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Medical Isotopes Market

  • 27.1. Russia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Medical Isotopes Market

  • 28.1. North America Medical Isotopes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Medical Isotopes Market

  • 29.1. USA Medical Isotopes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Medical Isotopes Market

  • 30.1. Canada Medical Isotopes Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Medical Isotopes Market

  • 31.1. South America Medical Isotopes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Medical Isotopes Market

  • 32.1. Brazil Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Medical Isotopes Market

  • 33.1. Middle East Medical Isotopes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Medical Isotopes Market

  • 34.1. Africa Medical Isotopes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Medical Isotopes Market Regulatory and Investment Landscape

36. Medical Isotopes Market Competitive Landscape And Company Profiles

  • 36.1. Medical Isotopes Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Medical Isotopes Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Medical Isotopes Market Company Profiles
    • 36.3.1. Rosatom State Atomic Energy Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. GE HealthCare Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Urenco Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Medical Isotopes Market Other Major And Innovative Companies

  • Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien Munchen AG (ITM), EczacIbasI-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions

38. Global Medical Isotopes Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Medical Isotopes Market

40. Medical Isotopes Market High Potential Countries, Segments and Strategies

  • 40.1 Medical Isotopes Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Medical Isotopes Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Medical Isotopes Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer